MST-Medical Surgery Technologies Ltd., an Israel-based leader in the field of advanced image-based robotic technology, announced on January 6 that the U.S. Food and Drug Administration (FDA) has cleared the Follow Me™ software designed for minimally invasive robotic surgery. Follow Me™ is an advanced function of MST’s AutoLap®, an image-guided laparoscope positioning system. Powered by MST’s image-based intelligence technology, AutoLap® enables full and natural control of the surgical procedure with minimal user interaction.
About Follow Me™
Follow Me™ enables the image-guided laparoscope to follow laparoscopic surgical tools without manual control. Using MST’s image analysis software, Follow Me™ allows the surgeon to virtually tag the surgical tools within the surgical cavity. The system interacts with the surgeon’s in-vivo movements and gestures, guiding the robotic laparoscope positioner to follow the surgeon’s tools in real time. With the Follow Me™ software the surgeon is able to fully focus on the procedure with an optimized surgical field of view, image stability and minimal distractions.
“Securing FDA clearance for the Follow-Me™ software is a major milestone for MST, making AutoLap® the only market-approved image-based system with image-guided functions for various minimally invasive laparoscopic procedures,” said Motti Frimer, CEO of MST. “We are already commercializing AutoLap® with the Follow Me™ software in Europe, and we now look forward to expanding marketing and sales of the surgeon-focused system in the U.S. in 2016.”
Source: MST